GT Medical Technologies, Inc. the provider of GammaTile® Therapy for the treatment of patients with operable brain tumors, has announced the promotion of Shane Brown to the position of President.  Matthew Likens, currently President and CEO will continue in his role as Chief Executive Officer.Continue reading→

TUCSON, Ariz., July 12, 2023 — Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at Sanford Research (CoRDS), in partnership with Cure MITO, will contribute its mitochondrial disorders data from its international patient registry to the C-Path-managed Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading→

The study identified likely cause of genetic disorder in six familiesContinue reading→

TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Rochester today announced the release of two seminal publications about digital health technologies for Parkinson’s. These technologies, such as smartphones and wearable sensors, offer an opportunity for objective, frequent and remote assessment of people with Parkinson’s.Continue reading→

Bringing a wide array of experience, Dr. Gabriel says ASU Health will be ‘different model altogether’ combining tech, innovation, industry and community needsContinue reading→

In 2021, Mayo Clinic announced plans to develop a biotechnology innovation hub called Discovery Oasis adjacent to Mayo Clinic Hospital in North Phoenix.

Two leaders have now been named to champion this organizational priority. Steven Lester, M.D., Mayo Clinic cardiologist and health care futurist, will serve as the medical director for Discovery Oasis. Aric Bopp, an experienced economic development leader, will serve as its executive director. Continue reading→

TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic scientists in advancing novel compounds through the drug development process. Launched in June 2022, TRxA is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics, from the lab to patientsContinue reading→

This Vital Health Podcast was recorded at the BIO international Conference on the afternoon of the release of Vital Transformation’s research study outlining the impacts of the Inflation Reduction Act on U.S. biopharma innovation. It features Duane Schulthess, Nick Shipley, the Executive Vice President of BIO, and Joe Hammang, Vital Transformation’s U.S. Business Director.Continue reading→

The Arizona Alzheimer’s Consortium 2023 Annual Scientific Conference will be held Monday, September 11, 2023 from 8:45am – 3:45pmat  
Arizona State University in Tempe. Continue reading→

INDIANAPOLIS—Langham Logistics, an Indiana-based warehousing and transportation company with a focus in life sciences, today announced an adaptation of the second half of its Arizona building to GMP controlled room space. More than 9,000 newly-converted controlled room temperature (CRT) pallet positions opened for full operations on June 1st to serve the West Coast’s cold chain warehousing and distribution demands.Continue reading→